Breast Cancer Clinical Trial
Measuring Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors
Summary
Current guidelines recommend endocrine treatment with aromatase inhibitors (AIs) in post-menopausal women with hormone receptor-positive breast cancer. Musculoskeletal symptoms are commonly reported with AI treatment,however, we do not have consistent methods to measure these symptoms prospectively. This gap in our knowledge inhibits the ability to test and develop treatments for AI-associated musculoskeletal symptoms. This pilot study will evaluate functional tests and standardized instruments for their ability to prospectively assess musculoskeletal symptoms in women being treated with AIs for breast cancer.
Full Description
Specific Aims: 1) identify a core set of instruments for measuring musculoskeletal symptoms, 2) model the time course and predictors of change in musculoskeletal symptoms, 3) explore the effect of musculoskeletal symptoms on adherence to AIs in women during the first 6 months of AI treatment.
Methods: We will prospectively assess musculoskeletal symptoms due to treatment with aromatase inhibitors. Post-menopausal women beginning AI treatment for hormone responsive breast cancer will be invited to join this study.
Eligibility Criteria
Inclusion Criteria:
Women with stage I - IIIa invasive breast cancer,
Hormone-receptor positive cancer (either ER+ or PR+ or both),
Prescribed and have agreed to take exemestane, anastrazole or letrozole,
Have completed initial treatment of surgery, RT, and/or chemotherapy,
Are post-menopausal,
No previous history of aromatase inhibitor therapy for invasive breast cancer,
Have signed the consent form.
Exclusion Criteria:
History of rheumatoid arthritis,
Unable to read or understand English,
History of psychiatric disability affecting informed consent or compliance with study procedures.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 2 Locations for this study
Robbinsdale Minnesota, 55422, United States
St. Louis Park Minnesota, 55426, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.